Anderson M, Svartengren M, Bylin G, Philipson K, Camner P
Department of Environmental Hygiene, Karolinska Institute, Stockholm, Sweden.
Am Rev Respir Dis. 1993 Mar;147(3):524-8. doi: 10.1164/ajrccm/147.3.524.
Ten subjects with asthma inhaled 3.6 micron particles labeled with 111In in air and in a helium-oxygen mixture (He-O2) at 0.5 and at 1.2 L/s. Lung retention was measured after zero and after 24 h, and the percentage 24-h retention (Ret24) was taken to represent the fraction deposited in the alveolar part of the lung. For both inhalation rates, Ret24 was significantly higher when particles were inhaled with He-O2 than with air. The increase in Ret24 seemed to be larger in subjects with asthma than in healthy persons earlier studied. Ret24 was correlated with changes in both large and small airways, especially when the particles were inhaled with He-O2. Our data suggest that inhalation of drugs in He-O2 might be of therapeutic value when treating patients with severely obstructed airways.
十名哮喘患者在空气中以及在氦氧混合气体(He-O2)中,以0.5升/秒和1.2升/秒的流速吸入标记有铟-111的3.6微米颗粒。在0小时和24小时后测量肺部滞留情况,24小时滞留率(Ret24)被用来代表沉积在肺肺泡部分的比例。对于两种吸入流速,当用He-O2吸入颗粒时,Ret24显著高于用空气吸入时。与之前研究的健康人相比,哮喘患者Ret24的增加似乎更大。Ret24与大气道和小气道的变化均相关,尤其是当用He-O2吸入颗粒时。我们的数据表明,对于气道严重阻塞的患者,在He-O2中吸入药物可能具有治疗价值。